These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32121)

  • 1. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of labetalol in experimental animals.
    Baum T; Sybertz EJ
    Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.
    Frishman W; Halprin S
    Am Heart J; 1979 Nov; 98(5):660-5. PubMed ID: 386753
    [No Abstract]   [Full Text] [Related]  

  • 6. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP; Bloomfield SS
    Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].
    Katano Y; Takeda K; Nakagawa Y; Hashimoto T; Nakazawa M; Tsukada T; Otorii T; Imai S
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):819-32. PubMed ID: 33880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 11. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
    J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.
    Cohen ML; Hynes LM
    Clin Exp Hypertens A; 1983; 5(4):563-75. PubMed ID: 6133660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM; Hilditch A; Levy GP
    Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha- and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1980 Jun; 9(6):621-3. PubMed ID: 6104500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.